NICE proposes restricting MS therapies

21st December 2017 Uncategorised 0

Novartis’ Extavia is the only beta interferon being endorsed by the National Institute for Health and Care Excellence as a cost-effective treatment option for multiple sclerosis.

More: NICE proposes restricting MS therapies
Source: News